Drawing for NANOPORTAL

USPTO serial 97382032

NANOPORTAL

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
HILLIARD, JESSICA LYNN
Law office
TMO LAW OFFICE 120

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NANOPORTAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott B. Dunbar

13170 TELFAIR AVEUNESYLMAR, CA 91342United States

Goods and services

ClassDescriptionStatusFirst use
001International Class 001: Nanoporous membranes in chemical form used in drug delivery devices injected through a small needle for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; nanoporous membranes in chemical form used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant; nanoporous membranes in chemical form used in drug delivery devices injected through a small needle for improving medication adherence in the treatment of chronic diseases, namely, metabolic diseases being diabetes, obesity or non- alcoholic steatohepatits, and psychological diseases being Alzheimer's, dementia, sociopathy or psychopathy; nanoporous membranes in chemical form used for improving medication adherence in the treatment of chronic diseases namely, metabolic diseases being diabetes, · obesity or non-alcoholic steatohepatits, and psychological diseases being Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases being diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases being Alzheimer's, dementia, sociopathy or psychopathyACTIVE—
005Implantable drug delivery devices injected through a small needle having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic diseases namely, metabolic diseases being diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases being Alzheimer's, dementia, sociopathy or psychopathyACTIVE—
010Implantable drug delivery devices injected through a small needle having a drug reservoir and a nanoporous membrane; miniature long-term drug implants utilizing proprietary implantable drug delivery technologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 28, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 11, 2026DOCKASSIGNED TO EXAMINER—
Apr 30, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Sep 3, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 3, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Sep 3, 2025CNSLSUSPENSION LETTER WRITTEN—
Jul 25, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 25, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 25, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 25, 2025NREVNOTICE OF REVIVAL - E-MAILED—
Jul 25, 2025PETGPETITION TO REVIVE-GRANTED—
Jul 25, 2025PROATEAS PETITION TO REVIVE RECEIVED—
Jul 22, 2025MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 22, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 7, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 24, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 24, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 27, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Nov 5, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 5, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 5, 2024ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 30, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 14, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 30, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 30, 2023GNSLLETTER OF SUSPENSION E-MAILED—
May 30, 2023CNSLSUSPENSION LETTER WRITTEN—
May 13, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 12, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 12, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 15, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 15, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 15, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2023DOCKASSIGNED TO EXAMINER—
May 2, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 29, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance